Proxy statement

OmniLit Acquisition Corp. (Nasdaq: OLIT) Announces Effectiveness of Registration Statement and October 31, 2023 Annual Meeting of Stockholders to Approve Business Combination with Syntec Optics, Inc.

Retrieved on: 
Friday, October 6, 2023
Transfer, Annual general meeting, Proxy statement, Acquisition, Internet, Bangladesh Securities and Exchange Commission, OLIT, Health, Proxy, Form, NUALS Arts and Literary Annual Meet, MIAMI, Annual, Auction, Holding company

Syntec Optics is a leading optics and photonics company for scientific and technical instruments, and aerospace and defense.

Key Points: 
  • Syntec Optics is a leading optics and photonics company for scientific and technical instruments, and aerospace and defense.
  • OmniLit will mail the definitive proxy statement/prospectus (the “Proxy Statement”) to stockholders of record as of the close of business on October 6, 2023.
  • The Proxy Statement contains a notice and voting instruction form or a proxy card relating to the special meeting of OmniLit’s stockholders (the “Annual Meeting”).
  • The Annual Meeting to approve the proposed business combination is scheduled to be held on October 31, 2023 at 11:00 a.m. Eastern Time via a virtual meeting format at https://www.colonialstock.com/omnilitacquisition.

Vyant Bio Announces Adjournment of Special Meeting of Stockholders

Retrieved on: 
Thursday, September 28, 2023
Dissolution, Proxy statement, Shareholder, Proxy card, 2015 Michigan Proposal 1, Special, Proxy, Proiphys, Asset purchase agreement, Sale, OTC, Security (finance), Holding company

The adjourned Special Meeting will reconvene on October 11, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .

Key Points: 
  • The adjourned Special Meeting will reconvene on October 11, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .
  • The record date of August 4, 2023 for the adjourned Special Meeting remains the same.
  • Proxies previously submitted will be voted at the adjourned Special Meeting, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
  • Vyant Bio encourages all stockholders, as of the record date on August 4, 2023, who have not yet voted to do so promptly.

Anzu Special Acquisition Corp I Stockholders Approve Business Combination with Envoy Medical Corporation

Retrieved on: 
Wednesday, September 27, 2023
Professional Services, Finance, Common stock, Proxy statement, Sub, Special, Proxy, Business analyst, Securities and Exchange Commission (Philippines), Acquisition, Security (finance), Holding company

Anzu Special Acquisition Corp I (the “Company”) (NASDAQ: “ANZU,” “ANZUU” and “ANZUW”), announced today that its stockholders voted to approve the Business Combination Agreement with Envoy Medical Corporation (“Envoy”), and the transactions contemplated thereby (the “Business Combination”) at the Company’s special meeting of stockholders held on September 27, 2023 (the “Special Meeting”).

Key Points: 
  • Anzu Special Acquisition Corp I (the “Company”) (NASDAQ: “ANZU,” “ANZUU” and “ANZUW”), announced today that its stockholders voted to approve the Business Combination Agreement with Envoy Medical Corporation (“Envoy”), and the transactions contemplated thereby (the “Business Combination”) at the Company’s special meeting of stockholders held on September 27, 2023 (the “Special Meeting”).
  • Pursuant to the Business Combination Agreement, Merger Sub will merge with and into Envoy, with Envoy surviving the merger as a wholly owned subsidiary of the Company (the “Merger”).
  • Following the closing of the Merger (the “Closing”), the Company will be renamed “Envoy Medical, Inc.”, which is referred to herein as “New Envoy.”
    Over 99% of the votes cast at the Special Meeting were cast in favor of the approval of the Business Combination.
  • The Company determined that the Extension Meeting is no longer necessary since the Business Combination is expected to close prior to September 30, 2023, its current business combination deadline.

Vyant Bio Announces Adjournment of Special Meeting of Stockholders

Retrieved on: 
Wednesday, September 20, 2023
Dissolution, Proxy statement, Proxy card, 2015 Michigan Proposal 1, Proxy, Proiphys, Asset purchase agreement, Sale, OTC, Special, Security (finance), Holding company

The adjourned Special Meeting will reconvene on September 28, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .

Key Points: 
  • The adjourned Special Meeting will reconvene on September 28, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .
  • The record date of August 4, 2023 for the adjourned Special Meeting remains the same.
  • Proxies previously submitted will be voted at the adjourned Special Meeting, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
  • Vyant Bio encourages all stockholders, as of the record date on August 4, 2023, who have not yet voted to do so promptly.

FTAC EMERALD ACQUISITION CORP. ANNOUNCES POSTPONEMENT OF SPECIAL MEETING IN LIEU OF ANNUAL MEETING OF STOCKHOLDERS

Retrieved on: 
Monday, September 18, 2023
Emerald, Proxy statement, Proxy, Meeting, Person, Sale, Suite, Prospectus, Security (finance), Arch Street (Philadelphia)

The price for any shares of Class A common stock properly redeemed in connection with the Meeting is estimated to be approximately $10.47 per share.

Key Points: 
  • The price for any shares of Class A common stock properly redeemed in connection with the Meeting is estimated to be approximately $10.47 per share.
  • There is no change to the location, record date, purpose or any of the proposals to be acted upon at the Meeting.
  • Stockholders who have already voted and do not wish to change their vote do not need to vote again.
  • The Company has mailed to its stockholders of record as of August 22, 2023 a definitive proxy statement (the “Proxy Statement”).

FTAC EMERALD ACQUISITION CORP. ANNOUNCES TIME CHANGE OF SPECIAL MEETING IN LIEU OF ANNUAL MEETING OF STOCKHOLDERS AND ESTIMATED REDEMPTION PRICE PER SHARE

Retrieved on: 
Friday, September 15, 2023
Emerald, Proxy statement, Proxy, Meeting, Person, Sale, Suite, Prospectus, Security (finance), Arch Street (Philadelphia)

The Company also announces that the price for any shares of Class A common stock properly redeemed in connection with the Meeting is estimated to be approximately $10.47 per share.

Key Points: 
  • The Company also announces that the price for any shares of Class A common stock properly redeemed in connection with the Meeting is estimated to be approximately $10.47 per share.
  • There is no change to the date, location, record date, purpose or any of the proposals to be acted upon at the Meeting.
  • Stockholders who have already voted and do not wish to change their vote do not need to vote again.
  • The Company has mailed to its stockholders of record as of August 22, 2023 a definitive proxy statement (the “Proxy Statement”).

FTAC EMERALD ACQUISITION CORP. ANNOUNCES ADJOURNMENT OF SPECIAL MEETING IN LIEU OF ANNUAL MEETING OF STOCKHOLDERS UNTIL 11:00 AM EASTERN TIME ON SEPTEMBER 18, 2023

Retrieved on: 
Tuesday, September 12, 2023
Emerald, Proxy statement, Proxy, Meeting, The Meeting, Person, Sale, Suite, Prospectus, Security (finance), Arch Street (Philadelphia)

The Meeting will be adjourned to September 18, 2023 at 11:00 a.m. Eastern Time.

Key Points: 
  • The Meeting will be adjourned to September 18, 2023 at 11:00 a.m. Eastern Time.
  • There is no change to the location, the record date, the purpose or any of the proposals to be acted upon at the Meeting.
  • Stockholders who have already voted and do not wish to change their vote do not need to vote again.
  • The Company has mailed to its stockholders of record as of August 22, 2023 a definitive proxy statement (the “Proxy Statement”).

AUGUSTA GOLD ANNOUNCES RESULTS OF ITS ANNUAL SHAREHOLDER MEETING

Retrieved on: 
Friday, September 8, 2023
Agreement, Plan, Proxy statement, Tripura Merger Agreement, Proxy, Annual general meeting, FSE, TSX, Remuneration, Appendix, Holding company, Audit

VANCOUVER, BC, Sept. 7, 2023 /PRNewswire/ - Augusta Gold Corp. (TSX: G) (OTCQB: AUGG) (FSE: 11B) ("Augusta Gold" or the "Company") announces that all matters presented for approval at Augusta Gold's annual shareholder meeting held today, as more particularly set out in the Company's management information circular and proxy statement for the Meeting (the "Proxy Statement"), have been approved.

Key Points: 
  • VANCOUVER, BC, Sept. 7, 2023 /PRNewswire/ - Augusta Gold Corp. (TSX: G) (OTCQB: AUGG) (FSE: 11B) ("Augusta Gold" or the "Company") announces that all matters presented for approval at Augusta Gold's annual shareholder meeting held today, as more particularly set out in the Company's management information circular and proxy statement for the Meeting (the "Proxy Statement"), have been approved.
  • These matters included:
    Electing each of the Company's six nominees as directors of the Company;
    Re-appointing Davidson & Company LLP as auditors of the Company for the ensuing year and authorizing the directors to fix their remuneration;
    Approving on an advisory, non-binding basis the resolutions regarding the compensation of the Company's named executive officers as described in the Proxy Statement; and
    Approving the Agreement and Plan of Merger (the "Merger Agreement") set forth as Appendix B to the Proxy Statement and the reincorporation of the Company in the State of Nevada pursuant to a merger with and into a wholly-owned subsidiary of the Company as set forth in the Merger Agreement and as more particularly set out in the Proxy Statement.
  • A summary of the results for the election of the Company's directors is provided below:

Tekla Funds Announce Adjournment of Special Meetings

Retrieved on: 
Monday, August 14, 2023
Asset Management, Professional Services, Finance, Proposal, HQL, Proxy statement, Proxy card, Proxy, Trustee, EDT, THQ, Special, Security (finance), THW

Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint special meetings of shareholders on August 14, 2023 (“Special Meetings”) were adjourned until August 29, 2023 to provide additional time for the Funds to reach a quorum on the proposal, described in their definitive joint proxy statement dated July 10, 2023 as filed with the Securities and Exchange Commission (the “Proxy Statement”), to approve a new investment advisory agreement with abrdn, Inc. (the “Proposal”).

Key Points: 
  • Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint special meetings of shareholders on August 14, 2023 (“Special Meetings”) were adjourned until August 29, 2023 to provide additional time for the Funds to reach a quorum on the proposal, described in their definitive joint proxy statement dated July 10, 2023 as filed with the Securities and Exchange Commission (the “Proxy Statement”), to approve a new investment advisory agreement with abrdn, Inc. (the “Proposal”).
  • The adjourned Special Meeting will recommence on August 29, 2023 at 9:00 a.m. EDT at the offices of the Funds, 100 Federal Street, Boston, MA.
  • The record date for the adjourned Special Meetings remains the same, June 16, 2023.
  • During the adjournment period, the Funds will continue to solicit votes from shareholders regarding the Proposal.

Calling All Electric Last Mile Solutions, Inc. (ELMSQ) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit

Retrieved on: 
Friday, August 11, 2023
Proxy statement, Proxy, GAAP, Person, BDO, Complaint, OTC, Court, Security (finance), Electricity

Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/elmsq .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/elmsq .
  • If you wish to review a copy of the Complaint, you can visit the firm’s site: www.bgandg.com/elmsq or you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.